These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3629752)

  • 1. Direct effects of oestradiol on growth and morphology of the Dunning R3327H prostatic carcinoma.
    Daehlin L; Bergh A; Damber JE
    Urol Res; 1987; 15(3):169-72. PubMed ID: 3629752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood flow in the Dunning R3327H rat prostatic adenocarcinoma; effects of oestradiol and testosterone.
    Daehlin L; Damber JE
    Urol Res; 1986; 14(2):113-7. PubMed ID: 3727214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the effects of oestrogen in the male. Some effects of different oestrogenic substances in rats and men with prostatic carcinoma.
    Daehlin L
    Scand J Urol Nephrol Suppl; 1985; 91():1-44. PubMed ID: 3868029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of medroxyprogesterone acetate, alone or in combination with epirubicin hydrochloride, on the growth of the Dunning R3327H prostatic adenocarcinoma.
    Landström M; Tomić R; Damber JE
    Eur Urol; 1987; 13(3):203-6. PubMed ID: 2956111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiestrogens do not counteract the inhibitory effect of estradiol-17 beta on the growth of the Dunning R3327 prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A; Tomic R; Carlsson-Bostedt L; Stigbrand T
    Prostate; 1988; 12(4):287-98. PubMed ID: 3393491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of castration, testosterone and oestrogen on epithelial and stromal growth and morphology of the Dunning (R3327H) prostatic adenocarcinoma.
    Damber JE; Landström M; Bergh A; Tomic R
    Scand J Urol Nephrol Suppl; 1988; 110():145-8. PubMed ID: 3187402
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of rat prostatic adenocarcinoma with medroxyprogesterone acetate (MPA): effects on growth and morphology.
    Damber JE; Bergh A; Landström M; Tomić R
    J Urol; 1991 Jun; 145(6):1283-7. PubMed ID: 1827847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oestrogen on growth and morphology of the Dunning R3327H prostatic carcinoma.
    Damber JE; Daehlin L; Bergh A; Landström M; Tomic R
    Prog Clin Biol Res; 1987; 243A():513-6. PubMed ID: 3659008
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A; Tomic R
    J Cancer Res Clin Oncol; 1992; 118(1):30-4. PubMed ID: 1729258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. After radiotherapy testosterone stimulation is unable to increase growth in the dunning R3327-PAP prostate tumour.
    Granfors T; Tomic R; Bergh A; Rydh M; Löfroth PO; Widmark A
    Urol Res; 1999 Oct; 27(5):357-61. PubMed ID: 10550524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of a cloned cell line R3327H-G8-A1 derived from the dunning R3327H rat adenocarcinoma.
    Sestili MA; Norris JS; Smith RG
    Cancer Res; 1983 May; 43(5):2167-75. PubMed ID: 6299542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal and chemotherapeutic treatment of prostatic carcinoma; Dunning adenocarcinoma of the prostate in Copenhagen-Fischer rats.
    Rosenberg CA; Hrushesky WJ; Langevin T; Kennedy BJ
    Oncology; 1985; 42(1):48-54. PubMed ID: 3969257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dunning adenocarcinoma in tissue culture: isolation of a cloned cell line, R3327H-G8-A1.
    Sestili MA; Norris JS; Lipschultz LI; Smith RG
    J Urol; 1982 Apr; 127(4):823-5. PubMed ID: 7040704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
    Sylvester PW; Ip MM
    Prostate; 1987; 10(1):57-67. PubMed ID: 3822918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen treatment of Dunning tumors in castrated rats: qualitative and quantitative morphology.
    Landström M; Bergh A; Thornell LE; Virtanen I; Damber JE
    Prostate; 1992; 20(3):199-211. PubMed ID: 1574467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the Dunning R3327 rat prostatic adenocarcinoma.
    Landström M; Bergh A; Tomic R; Damber JE
    Prostate; 1990; 17(1):57-68. PubMed ID: 1696714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dunning R3327-G prostate carcinoma of the rat: an appropriate model for drug evaluation.
    Kager M; Spruss T; Schneider MR; von Angerer E
    J Cancer Res Clin Oncol; 1992; 118(5):334-8. PubMed ID: 1583064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Castration plus oestrogen treatment induces but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocarcinoma.
    Westin P; Brändström A; Damber JE; Bergh A
    Br J Cancer; 1995 Jul; 72(1):140-5. PubMed ID: 7599043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental treatment of prostatic cancer by intermittent hormonal therapy.
    Trachtenberg J
    J Urol; 1987 Apr; 137(4):785-8. PubMed ID: 3560348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer.
    Smolev JK; Heston WD; Scott WW; Coffey DS
    Cancer Treat Rep; 1977; 61(2):273-87. PubMed ID: 872132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.